Skip to main content

Pharvaris N.V.

PHVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001830487

In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 23 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.24B in total; Viking Global Investors is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Pharvaris N.V. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
23 filings
10 insiders, $25.8M in total
Insiders trading
10
Net value
−$25.8M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Pharvaris N.V., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Pharvaris N.V.
NameTitleLast reported holdingLast filingFilings, past year
Monges VivianeDirector5,500Sep 25, 20262
Lu PengPresident110,261Sep 24, 202615
Schikan Johannes Gerardus Christiaan PetrusDirector115,167Sep 24, 20266
Nassif David W.CFO / CLO113,800Sep 23, 20262
Bjork ElisabethDirector15,167Sep 21, 20262
Glassman RobertDirector10,500Sep 21, 20264
Lesage AnneChief Early Development73,969IndirectSep 21, 20266
Modig BerndtChief Executive Officer650,000IndirectSep 21, 20268
Abele Stefan AndreasChief Technical Ops Officer39,068Sep 17, 20262
Souverijns WimChief Commercial Officer39,021Sep 16, 20262
Nijdam AnnaPrincipal Accounting Officer46,275Jun 8, 20265

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 25, 2026 (view filing)1:35 PM ETSep 232 daysMonges VivianeDirectorSSale−12.0K$33.05−$395.5K−68.5%5.50K after
Sep 24, 2026 (view filing)10:43 AM ETSep 222 daysSchikan Johannes Gerardus Christiaan PetrusDirectorSSale−800$36.19−$29.0K−0.7%115.2K after
Sep 23, 2026 (view filing)10:06 AM ETSep 212 daysNassif David W.CFO / CLOSSale−6.00K$36.47−$218.8K−5.0%114.3K after
Sep 21, 2026 (view filing)4:20 PM ETSep 174 daysLu PengPresidentSSale−100.0K$35.00−$3.50M−60.6%65.0K after
Sep 21, 2026 (view filing)4:18 PM ETSep 174 daysSchikan Johannes Gerardus Christiaan PetrusDirectorSSale−200.0K$35.00−$7.00M−63.5%115.2K after
Sep 21, 2026 (view filing)3:20 PM ETSep 174 daysBjork ElisabethDirectorSSale−52.5K$37.89−$1.99M−77.6%15.2K after
Sep 21, 2026 (view filing)3:16 PM ETSep 174 daysGlassman RobertDirectorSSale−14.5K$38.56−$558.8K−58.0%10.5K after
Sep 21, 2026 (view filing)3:13 PM ETSep 174 daysLesage AnneChief Early DevelopmentSSale−20.0K$38.27−$765.5K−21.3%74.0K after
Sep 17, 2026 (view filing)1:22 PM ETSep 152 daysAbele Stefan AndreasChief Technical Ops OfficerSSale−46.4K$38.17−$1.77M−54.3%39.1K after2 lots
Sep 17, 2026 (view filing)9:18 AM ETSep 152 daysGlassman RobertDirectorSSale−8.67K$38.27−$331.7K−45.2%10.5K after10b5-1
Sep 16, 2026 (view filing)2:07 PM ETSep 14-152 daysSouverijns WimChief Commercial OfficerSSale−26.1K$39.23−$1.02M−40.1%39.0K after2 lots10b5-1
Sep 15, 2026 (view filing)2:30 PM ETSep 114 daysLu PengPresidentSSale−15.0K$40.13−$601.9K−18.7%65.2K after10b5-1
Sep 15, 2026 (view filing)2:15 PM ETSep 141 dayModig BerndtChief Executive OfficerSSale−2.29K$39.40−$90.3K−1.8%128.3K after10b5-1
Sep 14, 2026 (view filing)12:29 PM ETSep 104 daysLesage AnneChief Early DevelopmentSSale−30.0K$38.30−$1.15M−34.7%56.5K after10b5-1
Sep 11, 2026 (view filing)12:25 PM ETSep 92 daysGlassman RobertDirectorSSale−8.00K$37.55−$300.4K−43.2%10.5K after10b5-1
Sep 9, 2026 (view filing)11:19 AM ETSep 81 dayLu PengPresidentSSale−15.0K$40.68−$610.1K−18.7%65.2K after10b5-1
Aug 18, 2026 (view filing)11:49 AM ETAug 144 daysModig BerndtChief Executive OfficerSSale−2.29K$34.77−$79.7K−1.7%130.6K after10b5-1
Jul 15, 2026 (view filing)1:08 PM ETJul 132 daysModig BerndtChief Executive OfficerSSale−2.29K$34.97−$80.2K−1.7%132.9K after10b5-1
Jul 1, 2026 (view filing)7:06 PM ETJun 29-302 daysSchikan Johannes Gerardus Christiaan PetrusDirectorSSale−37.6K$35.41−$1.33M−10.7%315.2K after2 lots10b5-1
Jul 1, 2026 (view filing)7:02 PM ETJun 29-302 daysLesage AnneChief Early DevelopmentSSale−38.5K$35.37−$1.36M−39.6%58.8K after3 lots10b5-1
Jul 1, 2026 (view filing)7:02 PM ETJun 29-302 daysLesage AnneChief Early DevelopmentSSale−37.7K$35.41−$1.33M−28.6%94.0K after2 lots10b5-1
Jun 29, 2026 (view filing)Jun 254 daysLesage AnneChief Early DevelopmentSSale−2.30K$35.12−$80.8K−3.9%56.5K after10b5-1
Jun 29, 2026 (view filing)Jun 254 daysLesage AnneChief Early DevelopmentSSale−2.30K$35.12−$80.8K−1.7%131.7K after10b5-1
Jun 29, 2026 (view filing)Jun 29Same daySchikan Johannes Gerardus Christiaan PetrusDirectorSSale−2.40K$35.10−$84.2K−0.7%352.8K after10b5-1
Jun 29, 2026 (view filing)Jun 25-264 daysLu PengChief Medical OfficerSSale−29.7K$34.30−$1.02M−31.2%65.6K after3 lots10b5-1
Jun 23, 2026 (view filing)Jun 185 daysLu PengChief Medical OfficerSSale−300$34.00−$10.2K−0.5%65.6K after10b5-1
Jun 17, 2026 (view filing)Jun 152 daysModig BerndtChief Executive OfficerSSale−2.29K$31.07−$71.2K−1.7%135.2K after2 lots10b5-1
Jun 8, 2026 (view filing)Jun 44 daysNijdam AnnaPrincipal Accounting OfficerSSale−2.67K$30.87−$82.4K−5.5%46.3K after
May 26, 2026 (view filing)May 215 daysMonges VivianeDirectorSSale−9.67K$30.29−$292.8K−63.7%5.50K after
May 26, 2026 (view filing)May 21-225 daysNijdam AnnaPrincipal Accounting OfficerSSale−7.33K$30.71−$225.1K−13.0%48.9K after2 lots
May 26, 2026 (view filing)May 215 daysNassif David W.CFO / CLOSSale−10.0K$30.31−$303.1K−7.7%120.3K after
May 22, 2026 (view filing)May 202 daysBjork ElisabethDirectorSSale−10.0K$29.32−$293.2K−39.7%15.2K after10b5-1
May 19, 2026 (view filing)May 154 daysGlassman RobertDirectorSSale−10.0K$29.83−$298.3K−48.8%10.5K after2 lots
May 19, 2026 (view filing)May 154 daysAbele Stefan AndreasChief Technical Ops OfficerSSale−8.75K$29.82−$260.9K−19.9%35.2K after
May 19, 2026 (view filing)May 154 daysSouverijns WimChief Commercial OfficerSSale−10.0K$29.92−$299.2K−18.1%45.1K after10b5-1
May 5, 2026 (view filing)May 14 daysLu PengChief Medical OfficerSSale−14.2K$30.17−$427.4K−17.7%66.1K after2 lots10b5-1
May 1, 2026 (view filing)Apr 29-302 daysSchikan Johannes Gerardus Christiaan PetrusDirectorSSale−32.9K$30.29−$996.5K−8.5%355.2K after3 lots10b5-1
May 1, 2026 (view filing)Apr 29-302 daysLesage AnneChief Early DevelopmentSSale−25.4K$30.23−$767.9K−31.0%56.5K after3 lots10b5-1
May 1, 2026 (view filing)Apr 29-302 daysLesage AnneChief Early DevelopmentSSale−22.9K$30.23−$692.2K−14.6%134.0K after2 lots10b5-1
May 1, 2026 (view filing)Apr 29-302 daysLu PengChief Medical OfficerSSale−18.7K$30.20−$565.8K−22.1%66.1K after2 lots10b5-1
Apr 24, 2026 (view filing)Apr 22-232 daysSchikan Johannes Gerardus Christiaan PetrusDirectorSSale−7.10K$30.05−$213.4K−1.8%388.1K after2 lots10b5-1
Apr 24, 2026 (view filing)Apr 22-232 daysLesage AnneChief Early DevelopmentSSale−7.60K$30.05−$228.4K−11.9%56.5K after3 lots10b5-1
Apr 24, 2026 (view filing)Apr 22-232 daysLesage AnneChief Early DevelopmentSSale−7.10K$30.05−$213.4K−4.3%156.9K after2 lots10b5-1
Apr 24, 2026 (view filing)Apr 22-232 daysLu PengChief Medical OfficerSSale−7.10K$30.05−$213.4K−9.7%66.1K after2 lots10b5-1
Apr 20, 2026 (view filing)Apr 164 daysModig BerndtChief Executive OfficerSSale−2.29K$28.60−$65.6K−1.6%139.8K after10b5-1
Apr 10, 2026 (view filing)Apr 91 dayModig BerndtChief Executive OfficerSSale−23.3K$27.75−$647.4K−14.1%142.1K after2 lots10b5-1